共 50 条
- [22] Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation ANNALS OF ONCOLOGY, 2016, 27 (12) : 2251 - 2257
- [24] Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation BONE MARROW TRANSPLANTATION, 2020, 55 (03) : 633 - 640
- [25] Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation Bone Marrow Transplantation, 2020, 55 : 633 - 640
- [29] Autologous stem cell transplantation followed by reduced intensity allogeneic stem cell transplantation (tandem transplantation) as treatment for advanced resistant Hodgkin's lymphoma patients. A retrospective analysis of the lymphoma working party (LWP) of the European group for blood and marrow transplantation (EBMT). BLOOD, 2006, 108 (11) : 866A - 866A